Status:
UNKNOWN
Systematic IPP VS Symptomatic IPP in GERD Prevention After POEM for Achalasia. . A Comparative Retrospective Analysis
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Achalasia
Gastroesophageal Reflux
Eligibility:
All Genders
18+ years
Brief Summary
POEM is a minimally invasive endoscopic therapy that is highly efficacy in the treatment of achalasia of any type. POEM has an increased risk of GERD. Systematic PPI therapy has never been studied for...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \> 18 years old
- Consent given
- Achalasia all types with eckhardt score \> 3
- Exclusion criteria:
- Patient who is a minor or under judicial protection
- Pregnant or breastfeeding woman
- Contraindication to PPIs
- Carrier of mediastinal and exogastric neoplasia
- Patient on PPIs prior to the procedure for indication that does not allow for their discontinuation
- Peptic esophagitis (Grade B, C or D) before or at the time of the procedure
- Previous treatment with Heller myotomy
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04740437
Start Date
January 1 2017
End Date
March 31 2022
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295